SD HEALTHCARE

Recent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...

ResMed’s CEO Eyes Greater Market Share

BIOTECH: Software Success To Move On to Analytics, AIFive years ago, Michael “Mick” Farrell listened to an analyst forecast ResMed’s demise.

Ionis Inks $1 Billion Deal with Biogen

Biogen will pay Carlsbad’s Ionis Pharmaceuticals $1 billion in cash as part of a 10-year collaboration around neurological drug development.

Tocagen Licenses Its Immunotherapy in China

Citing regulatory changes, San Diego’s Tocagen licensed its immunotherapy for commercialization in China, earning the company $16 million upfront and potentially much more.

French Company Acquires Astute Medical for $90 Million

French diagnostics giant bioMérieux acquired San Diego-based Astute Medical in a $90 million cash deal announced earlier this month.

Grossmont Clinic for Non-Emergency Conditions Opens

Sharp Grossmont Hospital has opened a new clinic, which looks to reduce patient volumes in the hospital’s emergency room, one of the busiest in San Diego County.

Irwin Jacobs, Martin Wygod Join Biological Dynamics Board

Biological Dynamics, a San Diego cancer diagnostics company, named Irwin Jacobs and Martin Wygod to its board, it was announced April 13.

Human Longevity, Inc. Teams with Nonprofit for Pilot Program

The company said the pilot program will put up to 100 San Diego Fire-Rescue Department firefighters and 10 alternates through screening, including genome sequencing.

Tandem Diabetes Care Continues Momentum in Preliminary Q1 Results

Tandem Diabetes Care reported a 42 percent year-over-year increase in preliminary quarter one sales, increasing the company’s stock.

Illumina, Loxo Oncology Partner on Cancer Diagnostic Solutions

San Diego-based Illumina, Inc. (Nasdaq: ILMN) and Loxo Oncology (Nasdaq: LOXO) in Stamford, Conn., announced on April 10, a global strategic partnership to develop and commercialize a multi-gene panel for broad tumor profiling.

Poseida Therapeutics Raises $30.5M to Further Develop Cancer Treatments

The biotechnology company described the financing round as oversubscribed.

Acadia Pharmaceuticals' Stock Tanks on Report of Deaths of Some Users of its Flagship Drug

Acadia fell from over $21 per share to $16.50 as of market close April 9.

Clarify Medical Taps Former Neothetics CEO as New Leader

Clarify Medical's CEO was formerly head of Neothetics, which merged into San Diego company Evofem Biosciences after its experimental drug failed in the clinic.